Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | NQO2 | P16083 | 1/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.47 |
| ▸ | BTK | Q06187 | 1/20 | 0.47 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.46 |
| ▸ | FEN1 | P39748 | 1/20 | 0.46 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL159458 | 1.00 | GPR3 (0.52) | GPR3KDM4ENQO2JAK2BTK | |
| Formic Acid SCHEMBL28434292 | 0.91 | GPR3 (0.44) | GPR3KDM4ENQO2JAK2BTK | |
| SCHEMBL7329420 | 0.78 | ELANE (0.46) | KDM4EHSD17B10HPGDALDH1A1GAA | |
| SCHEMBL12879832 | 0.78 | HSD17B10 (0.40) | KDM4EHSD17B10HPGDALDH1A1CYP2C19 | |
| SCHEMBL5263281 | 0.77 | PGR (0.50) | KDM4EHSD17B10HPGDALDH1A1GAA | |
| SCHEMBL18475321 | 0.76 | HSD17B10 (0.39) | KDM4EHSD17B10HPGDALDH1A1CYP2C19 | |
| SCHEMBL29642546 | 0.76 | HSD17B10 (0.39) | KDM4EHSD17B10HPGDALDH1A1CYP2C19 | |
| SCHEMBL29057018 | 0.76 | KDM4E (0.43) | KDM4EERCC1FEN1ERCC4HSD17B10 | |
| SCHEMBL29697555 | 0.76 | ELANE (0.39) | KDM4EHSD17B10HPGDALDH1A1CYP2C19 | |
| SCHEMBL2907333 | 0.76 | ELANE (0.42) | KDM4EHSD17B10HPGDALDH1A1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098059-A1 | COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS | ENDOMET BIOSCIENCES INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4720089-A1 | COMPOSITIONS AND METHODS FOR IMAGING AND TREATING ENDOMETRIOSIS | Endomet Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-12441768-B2 | Compositions and methods for treating endometriosis | ENDOMET BIOSCIENCES, INC. (US) | 2025-10-14 | — | — | US | claimed |
| US-20250241339-A1 | USE OF LACTIC ACID BACTERIA TO IMPROVE FEED EFFICIENCY | FONTERRA COOPERATIVE GROUP LTD (NZ) | 2025-07-31 | — | — | US | claimed |
| EP-4573503-A1 | METHODS, SYSTEMS, AND MEDIA METHOD APPLYING MACHINE LEARNING TO CHEMICAL MAPPING DATA FOR RNA TERTIARY STRUCTURE PREDICTION | Atomic AI, Inc. (US) | 2025-06-25 | — | — | EP | claimed |
| EP-4543219-A1 | USE OF LACTIC ACID BACTERIA TO IMPROVE FEED EFFICIENCY | Fonterra Co-Operative Group Ltd (NZ) | 2025-04-30 | — | — | EP | claimed |
| US-20250057898-A1 | USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS | FONTERRA COOPERATIVE GROUP LTD (NZ) | 2025-02-20 | — | — | US | claimed |
| CN-119486606-A | Use of lactic acid bacteria to increase feed efficiency | 方塔拉合作集团有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024243520-A1 | COMPOSITIONS AND METHODS FOR IMAGING AND TREATING ENDOMETRIOSIS | ENDOMET BIOSCIENCES, INC. (US) | 2024-11-28 | — | — | WO | claimed |
| EP-4451900-A1 | USE OF LACTIC ACID BACTERIA TO IMPROVE FEED EFFICIENCY | Fonterra Co-Operative Group Ltd (NZ) | 2024-10-30 | — | — | EP | claimed |
| US-20240079084-A1 | METHODS, SYSTEMS, AND MEDIA METHOD APPLYING MACHINE LEARNING TO CHEMICAL MAPPING DATA FOR RNA TERTIARY STRUCTURE PREDICTION | ATOMIC AI, INC. | 2024-03-07 | — | — | US | claimed |
| WO-2024039884-A1 | METHODS, SYSTEMS, AND MEDIA METHOD APPLYING MACHINE LEARNING TO CHEMICAL MAPPING DATA FOR RNA TERTIARY STRUCTURE PREDICTION | ATOMIC AI, INC. (US) | 2024-02-22 | — | — | WO | claimed |
| WO-2023248144-A1 | USE OF LACTIC ACID BACTERIA TO IMPROVE FEED EFFICIENCY | FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) | 2023-12-28 | — | — | WO | claimed |
| WO-2023235820-A1 | METHODS FOR OBTAINING RNA SECONDARY STRUCTURE OF LNP-ENCAPSULATED RNA | ECLIPSE BIOINNOVATIONS, INC. (US) | 2023-12-07 | — | — | WO | claimed |
| US-20230374566-A1 | METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-11-23 | — | — | US | claimed |
| EP-4217364-A1 | METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA | The Regents of the University of California (US) | 2023-08-02 | — | — | EP | claimed |
| WO-2023119206-A1 | USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS | FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) | 2023-06-29 | — | — | WO | claimed |
| WO-2023119207-A1 | USE OF LACTIC ACID BACTERIA TO IMPROVE FEED EFFICIENCY | FONTERRA CO-OPERATIVE GROUP LIMITED (NZ) | 2023-06-29 | — | — | WO | claimed |
| US-20220267838-A1 | Sensitive and Accurate Genome-wide Profiling of RNA Structure In Vivo | THE PENN STATE RESEARCH FOUNDATION | 2022-08-25 | — | — | US | claimed |
| WO-2022067036-A1 | METHODS OF IDENTIFYING PROTEIN BINDING SITES ON RNA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-03-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441768-B2 | Compositions and methods for treating endometriosis | CTNNB1, CTNNBL1, WNT3A | GPR3 1069/4885KDM4E 3713/4885NQO2 4633/4885 |
| US-20260098059-A1 | COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS | NR1H2, NR1H3, CTNND1 | GPR3 953/4885KDM4E 168/4885NQO2 4600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.